Astellas Pharma, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 13.37% vs 17.94% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 120.60% vs 2,561.14% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "524,320.00",
          "val2": "462,497.00",
          "chgp": "13.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "154,934.00",
          "val2": "110,543.00",
          "chgp": "40.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,693.00",
          "val2": "5,048.00",
          "chgp": "-46.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "79,213.00",
          "val2": "35,908.00",
          "chgp": "120.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "205.30%",
          "val2": "130.90%",
          "chgp": "7.44%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 19.25% vs 5.60% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 197.72% vs -82.73% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,912,323.00",
          "val2": "1,603,672.00",
          "chgp": "19.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "454,804.00",
          "val2": "335,910.00",
          "chgp": "35.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14,349.00",
          "val2": "9,368.00",
          "chgp": "53.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-190,558.00",
          "val2": "-127,136.00",
          "chgp": "-49.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "50,747.00",
          "val2": "17,045.00",
          "chgp": "197.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "133.70%",
          "val2": "111.00%",
          "chgp": "2.27%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

524,320.00

462,497.00

13.37%

Operating Profit (PBDIT) excl Other Income

154,934.00

110,543.00

40.16%

Interest

2,693.00

5,048.00

-46.65%

Exceptional Items

0.00

0.00

Consolidate Net Profit

79,213.00

35,908.00

120.60%

Operating Profit Margin (Excl OI)

205.30%

130.90%

7.44%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 13.37% vs 17.94% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 120.60% vs 2,561.14% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,912,323.00

1,603,672.00

19.25%

Operating Profit (PBDIT) excl Other Income

454,804.00

335,910.00

35.39%

Interest

14,349.00

9,368.00

53.17%

Exceptional Items

-190,558.00

-127,136.00

-49.89%

Consolidate Net Profit

50,747.00

17,045.00

197.72%

Operating Profit Margin (Excl OI)

133.70%

111.00%

2.27%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 19.25% vs 5.60% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 197.72% vs -82.73% in Mar 2024

All Annual Results